Key result
Perioperative hemolysis and endothelial activation after LVAD are linked to significantly lower 1-year eGFR trajectories.
Why the study?
Kidney dysfunction is common after LVAD implantation and is associated with adverse outcomes. The relationships between patient factors, hemolysis and endothelial activation markers, and kidney outcomes in LVAD recipients required evaluation.
Does worsening perioperative hemolysis and endothelial activation impair 1-year eGFR trajectory in LVAD recipients?
Cohort (n=25)
Does worsening perioperative hemolysis and endothelial activation impair 1-year eGFR trajectory in LVAD recipients?
Worsening perioperative hemolysis and endothelial activation occur in nearly half of LVAD recipients and are significantly associated with a lower eGFR trajectory over 1 year.
Answers are grounded in this paper and cite their sources.
Hemolysis may contribute to endothelial and kidney dysfunction in LVAD recipients; leaves open whether mitigation improves outcomes.
Background Kidney dysfunction is common after LVAD implantation and associated with adverse outcomes. Hemolysis and endothelial dysfunction may contribute to this. We evaluated the relationships between patient factors, hemolysis and endothelial activation markers, and kidney outcomes in LVAD recipients. Methods We analyzed the plasma proteome from 25 LVAD recipients with samples collected pre-op and on day 7 using LC/MS-MS. We included proteins detected in >50% of samples. Hemolysis- and endothelial-related proteins were identified, and principal component analysis (PCA) was applied separately to the panels. The first principal component (PC) for each panel was used as a summary measure for that process. Logistic regression was used to assess the relationship of patient factors with the processes. eGFR over 1 year after implantation was modeled using generalized additive mixed models. Results 25 LVAD recipients (age 60±12 years; 32% female; 40% Black) were enrolled. 563 proteins met inclusion criteria. We identified 10 hemolysis-related and 11 endothelial activation proteins. The first PC accounted for 43.6% of the hemolysis variance and 30.1% of the endothelial variance. Changes in hemolysis and endothelial scores from pre-op to day 7 were correlated (Panel A). 12 of 25 patients (48%) had increase in hemolysis or endothelial scores from pre-op to day 7. Black race was the one factor associated with higher odds of increased hemolysis or endothelial score (Panel B, P=0.02). eGFR trajectory was significantly lower in those who had increases in hemolysis or endothelial scores (Panel C, P<0.001). Conclusion Nearly half of LVAD recipients experienced worsening perioperative hemolysis and endothelial activation. These changes were linked to each other and with worse kidney function after implantation, suggesting these processes may contribute to kidney dysfunction in this setting.
No takes yet. Share an insight, caveat, or question.
Walther et al. (2026) conducted a cohort in Left ventricular assist device (LVAD) recipients (n=25). Increased hemolysis or endothelial activation scores from pre-op to day 7 vs. No increase in hemolysis or endothelial activation scores from pre-op to day 7 was evaluated on eGFR trajectory over 1 year after LVAD implantation (p=<0.001). Increases in perioperative hemolysis or endothelial activation scores occurred in 48% of LVAD recipients and were associated with a lower 1-year eGFR trajectory.
Synapse has enriched 10 related papers. Consider them for comparative context: